Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-19
Pages: 97 Pages
Report ld: 4677265
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Spine Biologics Market Size(US$)
CAGR 2025-2031
3.3%
Market Size,2031
USD 3,153
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,595 million
Market Forecast in 2031(Value)
US$ 3,153 million
CAGR
3.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.
North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.
In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.
The global Spine Biologics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Medtronic
- Depuy Synthes
- Stryker Corporation
- Nuvasive
- Zimmer Biomet
- Orthofix International
- Globus Medical
- alphatec spine
- K2M
- Exactech
- Wright Medical Technology
- X-Spine
- Nutech
- Arthrex
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- BMAC (Bone Marrow Aspirate Concentrate)
Segment by Application
- Anterior Cervical Discectomy and Fusion
- Posterior Lumbar Interbody Fusion
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Spine Biologics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Bone Graft Substitute in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Posterior Lumbar Interbody Fusion in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Spine Biologics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Spine Biologics Product Scope
1.2 Spine Biologics by Type
1.2.1 Global Spine Biologics Sales by Type (2020 & 2024 & 2031)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Spine Biologics by Application
1.3.1 Global Spine Biologics Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Estimates and Forecasts (2020-2031)
1.4.1 Global Spine Biologics Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Spine Biologics Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Spine Biologics Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Spine Biologics Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Spine Biologics Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Spine Biologics Sales Market Share by Region (2020-2025)
2.2.2 Global Spine Biologics Revenue Market Share by Region (2020-2025)
2.3 Global Spine Biologics Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Spine Biologics Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Spine Biologics Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Spine Biologics Market Size and Prospective (2020-2031)
2.4.2 Europe Spine Biologics Market Size and Prospective (2020-2031)
2.4.3 China Spine Biologics Market Size and Prospective (2020-2031)
2.4.4 Japan Spine Biologics Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Spine Biologics Historic Market Review by Type (2020-2025)
3.1.1 Global Spine Biologics Sales by Type (2020-2025)
3.1.2 Global Spine Biologics Revenue by Type (2020-2025)
3.1.3 Global Spine Biologics Price by Type (2020-2025)
3.2 Global Spine Biologics Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Spine Biologics Sales Forecast by Type (2026-2031)
3.2.2 Global Spine Biologics Revenue Forecast by Type (2026-2031)
3.2.3 Global Spine Biologics Price Forecast by Type (2026-2031)
3.3 Different Types Spine Biologics Representative Players
4 Global Market Size by Application
4.1 Global Spine Biologics Historic Market Review by Application (2020-2025)
4.1.1 Global Spine Biologics Sales by Application (2020-2025)
4.1.2 Global Spine Biologics Revenue by Application (2020-2025)
4.1.3 Global Spine Biologics Price by Application (2020-2025)
4.2 Global Spine Biologics Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Spine Biologics Sales Forecast by Application (2026-2031)
4.2.2 Global Spine Biologics Revenue Forecast by Application (2026-2031)
4.2.3 Global Spine Biologics Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Spine Biologics Application
5 Competition Landscape by Players
5.1 Global Spine Biologics Sales by Players (2020-2025)
5.2 Global Top Spine Biologics Players by Revenue (2020-2025)
5.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2024)
5.4 Global Spine Biologics Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Spine Biologics, Product Type & Application
5.7 Global Key Manufacturers of Spine Biologics, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Spine Biologics Sales by Company
6.1.1.1 North America Spine Biologics Sales by Company (2020-2025)
6.1.1.2 North America Spine Biologics Revenue by Company (2020-2025)
6.1.2 North America Spine Biologics Sales Breakdown by Type (2020-2025)
6.1.3 North America Spine Biologics Sales Breakdown by Application (2020-2025)
6.1.4 North America Spine Biologics Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Spine Biologics Sales by Company
6.2.1.1 Europe Spine Biologics Sales by Company (2020-2025)
6.2.1.2 Europe Spine Biologics Revenue by Company (2020-2025)
6.2.2 Europe Spine Biologics Sales Breakdown by Type (2020-2025)
6.2.3 Europe Spine Biologics Sales Breakdown by Application (2020-2025)
6.2.4 Europe Spine Biologics Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Spine Biologics Sales by Company
6.3.1.1 China Spine Biologics Sales by Company (2020-2025)
6.3.1.2 China Spine Biologics Revenue by Company (2020-2025)
6.3.2 China Spine Biologics Sales Breakdown by Type (2020-2025)
6.3.3 China Spine Biologics Sales Breakdown by Application (2020-2025)
6.3.4 China Spine Biologics Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Spine Biologics Sales by Company
6.4.1.1 Japan Spine Biologics Sales by Company (2020-2025)
6.4.1.2 Japan Spine Biologics Revenue by Company (2020-2025)
6.4.2 Japan Spine Biologics Sales Breakdown by Type (2020-2025)
6.4.3 Japan Spine Biologics Sales Breakdown by Application (2020-2025)
6.4.4 Japan Spine Biologics Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Medtronic Spine Biologics Products Offered
7.1.5 Medtronic Recent Development
7.2 Depuy Synthes
7.2.1 Depuy Synthes Company Information
7.2.2 Depuy Synthes Business Overview
7.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Depuy Synthes Spine Biologics Products Offered
7.2.5 Depuy Synthes Recent Development
7.3 Stryker Corporation
7.3.1 Stryker Corporation Company Information
7.3.2 Stryker Corporation Business Overview
7.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Stryker Corporation Spine Biologics Products Offered
7.3.5 Stryker Corporation Recent Development
7.4 Nuvasive
7.4.1 Nuvasive Company Information
7.4.2 Nuvasive Business Overview
7.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Nuvasive Spine Biologics Products Offered
7.4.5 Nuvasive Recent Development
7.5 Zimmer Biomet
7.5.1 Zimmer Biomet Company Information
7.5.2 Zimmer Biomet Business Overview
7.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Zimmer Biomet Spine Biologics Products Offered
7.5.5 Zimmer Biomet Recent Development
7.6 Orthofix International
7.6.1 Orthofix International Company Information
7.6.2 Orthofix International Business Overview
7.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Orthofix International Spine Biologics Products Offered
7.6.5 Orthofix International Recent Development
7.7 Globus Medical
7.7.1 Globus Medical Company Information
7.7.2 Globus Medical Business Overview
7.7.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Globus Medical Spine Biologics Products Offered
7.7.5 Globus Medical Recent Development
7.8 alphatec spine
7.8.1 alphatec spine Company Information
7.8.2 alphatec spine Business Overview
7.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.8.4 alphatec spine Spine Biologics Products Offered
7.8.5 alphatec spine Recent Development
7.9 K2M
7.9.1 K2M Company Information
7.9.2 K2M Business Overview
7.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.9.4 K2M Spine Biologics Products Offered
7.9.5 K2M Recent Development
7.10 Exactech
7.10.1 Exactech Company Information
7.10.2 Exactech Business Overview
7.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Exactech Spine Biologics Products Offered
7.10.5 Exactech Recent Development
7.11 Wright Medical Technology
7.11.1 Wright Medical Technology Company Information
7.11.2 Wright Medical Technology Business Overview
7.11.3 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Wright Medical Technology Spine Biologics Products Offered
7.11.5 Wright Medical Technology Recent Development
7.12 X-Spine
7.12.1 X-Spine Company Information
7.12.2 X-Spine Business Overview
7.12.3 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.12.4 X-Spine Spine Biologics Products Offered
7.12.5 X-Spine Recent Development
7.13 Nutech
7.13.1 Nutech Company Information
7.13.2 Nutech Business Overview
7.13.3 Nutech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Nutech Spine Biologics Products Offered
7.13.5 Nutech Recent Development
7.14 Arthrex
7.14.1 Arthrex Company Information
7.14.2 Arthrex Business Overview
7.14.3 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Arthrex Spine Biologics Products Offered
7.14.5 Arthrex Recent Development
8 Spine Biologics Manufacturing Cost Analysis
8.1 Spine Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Spine Biologics
8.4 Spine Biologics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Spine Biologics Distributors List
9.3 Spine Biologics Customers
10 Spine Biologics Market Dynamics
10.1 Spine Biologics Industry Trends
10.2 Spine Biologics Market Drivers
10.3 Spine Biologics Market Challenges
10.4 Spine Biologics Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Spine Biologics Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Spine Biologics Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Spine Biologics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Spine Biologics Sales (K Units) by Region (2020-2025)
Table 5. Global Spine Biologics Sales Market Share by Region (2020-2025)
Table 6. Global Spine Biologics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Spine Biologics Revenue Share by Region (2020-2025)
Table 8. Global Spine Biologics Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Spine Biologics Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Spine Biologics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Spine Biologics Revenue Share Forecast by Region (2026-2031)
Table 12. Global Spine Biologics Sales by Type (K Units) & (2020-2025)
Table 13. Global Spine Biologics Sales Share by Type (2020-2025)
Table 14. Global Spine Biologics Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Spine Biologics Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Spine Biologics Sales by Type (K Units) & (2026-2031)
Table 17. Global Spine Biologics Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Spine Biologics Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Spine Biologics Sales by Application (K Units) & (2020-2025)
Table 21. Global Spine Biologics Sales Share by Application (2020-2025)
Table 22. Global Spine Biologics Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Spine Biologics Price by Application (USD/Unit) & (2020-2025)
Table 24. Global Spine Biologics Sales by Application (K Units) & (2026-2031)
Table 25. Global Spine Biologics Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Spine Biologics Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Spine Biologics Application
Table 28. Global Spine Biologics Sales by Company (K Units) & (2020-2025)
Table 29. Global Spine Biologics Sales Share by Company (2020-2025)
Table 30. Global Spine Biologics Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Spine Biologics Revenue Share by Company (2020-2025)
Table 32. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2024)
Table 33. Global Market Spine Biologics Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Spine Biologics, Product Type & Application
Table 36. Global Key Manufacturers of Spine Biologics, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Spine Biologics Sales by Company (2020-2025) & (K Units)
Table 39. North America Spine Biologics Sales Market Share by Company (2020-2025)
Table 40. North America Spine Biologics Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Spine Biologics Revenue Market Share by Company (2020-2025)
Table 42. North America Spine Biologics Sales by Type (2020-2025) & (K Units)
Table 43. North America Spine Biologics Sales Market Share by Type (2020-2025)
Table 44. North America Spine Biologics Sales by Application (2020-2025) & (K Units)
Table 45. North America Spine Biologics Sales Market Share by Application (2020-2025)
Table 46. Europe Spine Biologics Sales by Company (2020-2025) & (K Units)
Table 47. Europe Spine Biologics Sales Market Share by Company (2020-2025)
Table 48. Europe Spine Biologics Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Spine Biologics Revenue Market Share by Company (2020-2025)
Table 50. Europe Spine Biologics Sales by Type (2020-2025) & (K Units)
Table 51. Europe Spine Biologics Sales Market Share by Type (2020-2025)
Table 52. Europe Spine Biologics Sales by Application (2020-2025) & (K Units)
Table 53. Europe Spine Biologics Sales Market Share by Application (2020-2025)
Table 54. China Spine Biologics Sales by Company (2020-2025) & (K Units)
Table 55. China Spine Biologics Sales Market Share by Company (2020-2025)
Table 56. China Spine Biologics Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Spine Biologics Revenue Market Share by Company (2020-2025)
Table 58. China Spine Biologics Sales by Type (2020-2025) & (K Units)
Table 59. China Spine Biologics Sales Market Share by Type (2020-2025)
Table 60. China Spine Biologics Sales by Application (2020-2025) & (K Units)
Table 61. China Spine Biologics Sales Market Share by Application (2020-2025)
Table 62. Japan Spine Biologics Sales by Company (2020-2025) & (K Units)
Table 63. Japan Spine Biologics Sales Market Share by Company (2020-2025)
Table 64. Japan Spine Biologics Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Spine Biologics Revenue Market Share by Company (2020-2025)
Table 66. Japan Spine Biologics Sales by Type (2020-2025) & (K Units)
Table 67. Japan Spine Biologics Sales Market Share by Type (2020-2025)
Table 68. Japan Spine Biologics Sales by Application (2020-2025) & (K Units)
Table 69. Japan Spine Biologics Sales Market Share by Application (2020-2025)
Table 70. Medtronic Company Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Spine Biologics Product
Table 74. Medtronic Recent Development
Table 75. Depuy Synthes Company Information
Table 76. Depuy Synthes Description and Business Overview
Table 77. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Depuy Synthes Spine Biologics Product
Table 79. Depuy Synthes Recent Development
Table 80. Stryker Corporation Company Information
Table 81. Stryker Corporation Description and Business Overview
Table 82. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Stryker Corporation Spine Biologics Product
Table 84. Stryker Corporation Recent Development
Table 85. Nuvasive Company Information
Table 86. Nuvasive Description and Business Overview
Table 87. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Nuvasive Spine Biologics Product
Table 89. Nuvasive Recent Development
Table 90. Zimmer Biomet Company Information
Table 91. Zimmer Biomet Description and Business Overview
Table 92. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Zimmer Biomet Spine Biologics Product
Table 94. Zimmer Biomet Recent Development
Table 95. Orthofix International Company Information
Table 96. Orthofix International Description and Business Overview
Table 97. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Orthofix International Spine Biologics Product
Table 99. Orthofix International Recent Development
Table 100. Globus Medical Company Information
Table 101. Globus Medical Description and Business Overview
Table 102. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Globus Medical Spine Biologics Product
Table 104. Globus Medical Recent Development
Table 105. alphatec spine Company Information
Table 106. alphatec spine Description and Business Overview
Table 107. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. alphatec spine Spine Biologics Product
Table 109. alphatec spine Recent Development
Table 110. K2M Company Information
Table 111. K2M Description and Business Overview
Table 112. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. K2M Spine Biologics Product
Table 114. K2M Recent Development
Table 115. Exactech Company Information
Table 116. Exactech Description and Business Overview
Table 117. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Exactech Spine Biologics Product
Table 119. Exactech Recent Development
Table 120. Wright Medical Technology Company Information
Table 121. Wright Medical Technology Description and Business Overview
Table 122. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Wright Medical Technology Spine Biologics Product
Table 124. Wright Medical Technology Recent Development
Table 125. X-Spine Company Information
Table 126. X-Spine Description and Business Overview
Table 127. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. X-Spine Spine Biologics Product
Table 129. X-Spine Recent Development
Table 130. Nutech Company Information
Table 131. Nutech Description and Business Overview
Table 132. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Nutech Spine Biologics Product
Table 134. Nutech Recent Development
Table 135. Arthrex Company Information
Table 136. Arthrex Description and Business Overview
Table 137. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Arthrex Spine Biologics Product
Table 139. Arthrex Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Spine Biologics Distributors List
Table 143. Spine Biologics Customers List
Table 144. Spine Biologics Market Trends
Table 145. Spine Biologics Market Drivers
Table 146. Spine Biologics Market Challenges
Table 147. Spine Biologics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Spine Biologics Product Picture
Figure 2. Global Spine Biologics Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Spine Biologics Sales Market Share by Type in 2024 & 2031
Figure 4. Bone Graft Product Picture
Figure 5. Bone Graft Substitute Product Picture
Figure 6. Platelet Rich Plasma (PRP) Product Picture
Figure 7. BMAC (Bone Marrow Aspirate Concentrate) Product Picture
Figure 8. Global Spine Biologics Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Spine Biologics Sales Market Share by Application in 2024 & 2031
Figure 10. Anterior Cervical Discectomy and Fusion Examples
Figure 11. Posterior Lumbar Interbody Fusion Examples
Figure 12. Others Examples
Figure 13. Global Spine Biologics Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Spine Biologics Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Spine Biologics Sales (K Units) Growth Rate (2020-2031)
Figure 16. Global Spine Biologics Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 17. Spine Biologics Report Years Considered
Figure 18. Global Market Spine Biologics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Spine Biologics Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Spine Biologics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Spine Biologics Sales (K Units) Growth Rate (2020-2031)
Figure 22. Europe Spine Biologics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Spine Biologics Sales (K Units) Growth Rate (2020-2031)
Figure 24. China Spine Biologics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Spine Biologics Sales (K Units) Growth Rate (2020-2031)
Figure 26. Japan Spine Biologics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Spine Biologics Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Spine Biologics Revenue Share by Type (2020-2025)
Figure 29. Global Spine Biologics Sales Share by Type (2026-2031)
Figure 30. Global Spine Biologics Revenue Share by Type (2026-2031)
Figure 31. Global Spine Biologics Revenue Share by Application (2020-2025)
Figure 32. Global Spine Biologics Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Spine Biologics Sales Share by Application (2026-2031)
Figure 34. Global Spine Biologics Revenue Share by Application (2026-2031)
Figure 35. Global Spine Biologics Sales Share by Company (2024)
Figure 36. Global Spine Biologics Revenue Share by Company (2024)
Figure 37. Global 5 Largest Spine Biologics Players Market Share by Revenue in Spine Biologics: 2020 & 2024
Figure 38. Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Spine Biologics
Figure 40. Manufacturing Process Analysis of Spine Biologics
Figure 41. Spine Biologics Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Spine Biologics in 2025?
The global market size of Spine Biologics in 2025 was 2595 Million USD.
What was the global market size of Spine Biologics in 2031?
What is the annual compound growth rate of the global Spine Biologics market size from 2025 to 2031?
Which companies rank high in the global Spine Biologics market?
Which region is expected to have the highest market share?
Related Reports
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 169
USD 4900.00
(Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 137
USD 4250.00
(Single User License)
Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 121
USD 2900.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 142
USD 3950.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 164
USD 4900.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 152
USD 5900.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 121
USD 3950.00
(Single User License)
Global Spine Biologics Market Research Report 2025
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-17
Pages: 161
USD 5600.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-16
Pages: 150
USD 5900.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 169
USD 4900.00 (Single User License)Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 137
USD 4250.00 (Single User License)Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 121
USD 2900.00 (Single User License)Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 142
USD 3950.00 (Single User License)Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 164
USD 4900.00 (Single User License)Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 152
USD 5900.00 (Single User License)Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 121
USD 3950.00 (Single User License)Global Spine Biologics Market Research Report 2025
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-01-16
Pages: 91
USD 2900.00 (Single User License)Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-17
Pages: 161
USD 5600.00 (Single User License)Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-16
Pages: 150
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now